Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coa...
Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants
About this item
Full title
Author / Creator
Publisher
China: Elsevier B.V
Journal title
Language
English
Formats
Publication information
Publisher
China: Elsevier B.V
Subjects
More information
Scope and Contents
Contents
Sofosbuvir is one of the new direct-acting antiviral drugs against hepatitis C virus (HCV) infection. This drug has recently been launched into the market, and generic versions of the medication are expected to be produced by local drug producers in some countries. Therefore, new methods are required to control sofosbuvir in pharmaceuticals. In the...
Alternative Titles
Full title
Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f548b34e335d4f9f87c3bf63eda4597b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f548b34e335d4f9f87c3bf63eda4597b
Other Identifiers
ISSN
2095-1779
E-ISSN
2214-0883
DOI
10.1016/j.jpha.2017.04.003
